SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-19-000043
Filing Date
2019-08-01
Accepted
2019-08-01 07:25:32
Documents
4
Period of Report
2019-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 34876
2 EXHIBIT 99.1 a190801pirsprmayasaidapp.htm EX-99.1 7643
3 a190801pirsprmayasaidapp001.jpg GRAPHIC 267980
4 a190801pirsprmayasaidapp002.jpg GRAPHIC 220784
  Complete submission text file 0001583648-19-000043.txt   717224
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 19990934
SIC: 8731 Services-Commercial Physical & Biological Research